Profiel
Richard Walovitch was Senior Vice President-Clinical Research of Acusphere, Inc. from 2005 to January 2009 and Vice President-Clinical Research from 1997 to January 2009.
Prior to joining Acusphere, he was Vice President-Pre clinical and Clinical Research at Epix Medical, Inc. from 1993 to 1997 and the International Project Clinician at DuPont Merck Pharmaceutical Company from 1988 to 1993.
Dr. Walovitch received a BS in Biology and a PhD in Pharmacology from the University of Illinois.
Eerdere bekende functies van Richard Walovitch
| Bedrijven | Functie | Einde |
|---|---|---|
| ACUSPHERE, INC. | Hoofd Techniek/Wetenschap/O&O | 08-01-2009 |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 |
Opleiding van Richard Walovitch
| University of Illinois | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ACUSPHERE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
